Garrison J. Hasara, CFO and Treasurer at Inhibitor Therapeutics, Inc. (INTI), bought 13,500 shares at $0.07 ($945) on 2019-12-02, disclosed to the SEC on 2019-12-02.
Open-market purchase of $945 INTI by CFO and Treasurer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.